Roberto Ruiu

Turin, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

OligoDOMTM: a T-cell response-enhancing platform applied to cancer immunotherapy.

OligoDOMTM: a T-cell response-enhancing platform applied to cancer immunotherapy.

Journal: Frontiers in immunology

Published: December 20, 2024

Cystine/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system function in breast cancer mouse models.

Cystine/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system function in breast cancer mouse models.

Journal: Journal of experimental & clinical cancer research : CR

Published: June 02, 2023

Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy.

Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy.

Journal: Oncoimmunology

Published: June 27, 2022

Are Cancer Stem Cells a Suitable Target for Breast Cancer Immunotherapy?

Are Cancer Stem Cells a Suitable Target for Breast Cancer Immunotherapy?

Journal: Frontiers in oncology

Published: February 16, 2022

Intracellular Water Lifetime as a Tumor Biomarker to Monitor Doxorubicin Treatment via FFC-Relaxometry in a Breast Cancer Model.

Intracellular Water Lifetime as a Tumor Biomarker to Monitor Doxorubicin Treatment via FFC-Relaxometry in a Breast Cancer Model.

Journal: Frontiers in oncology

Published: September 20, 2021

Teneurins: Role in Cancer and Potential Role as Diagnostic Biomarkers and Targets for Therapy.

Teneurins: Role in Cancer and Potential Role as Diagnostic Biomarkers and Targets for Therapy.

Journal: International journal of molecular sciences

Published: February 08, 2021

Identification of TENM4 as a Novel Cancer Stem Cell-Associated Molecule and Potential Target in Triple Negative Breast Cancer.

Identification of TENM4 as a Novel Cancer Stem Cell-Associated Molecule and Potential Target in Triple Negative Breast Cancer.

Journal: Cancers

Published: December 24, 2020

Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies.

Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies.

Journal: Cells

Published: November 25, 2020

Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer.

Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer.

Journal: Cancer immunology research

Published: January 28, 2020

L-ferritin: A theranostic agent of natural origin for MRI visualization and treatment of breast cancer.

L-ferritin: A theranostic agent of natural origin for MRI visualization and treatment of breast cancer.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: September 06, 2019

Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source.

Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source.

Journal: Progress in molecular biology and translational science

Published: August 07, 2019

Fighting breast cancer stem cells through the immune-targeting of the xCT cystine-glutamate antiporter.

Fighting breast cancer stem cells through the immune-targeting of the xCT cystine-glutamate antiporter.

Journal: Cancer immunology, immunotherapy : CII

Published: March 05, 2018

Showing 1-12 of 19

Last Updated: 09/26/2026